Retinoids, a class of compounds including retinol (vitamin A) and its natural (e.g., retinaldehyde and retinoic acid) and synthetic analogues, exert striking effects on cell proliferation, differentiation, and pattern formation during development (for reviews, see refs. 1 and 2). For instance, retinoic acid can mimic the action of the influential group of cells, the zone of polarizing activity, in the developing chick limb bud (3, 4) , and retinoids cause specific alterations in the proximodistal pattern of regenerating amphibian limbs (5) . In addition, retinoids can suppress the process of carcinogenesis in vivo (6) and the development of the malignant phenotype in vitro (2) . The molecular mechanism(s) by which retinoids exert such potent effects on the growth, differentiation, and neoplastic transformation of a variety of different cell types have not been elucidated, even though many of these effects of retinoids have been known for over 60 years.
Retinoids induce differentiation and consequently modify gene expression in several types of cultured cells. Specific cellular genes induced by retinoids have been identified and cloned from differentiating HL-60 promyelocytic leukemia cells (7) , cultured human epidermal keratinocytes (8) , and murine teratocarcinoma cells (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . However, the relatively slow time courses of induction suggest that the genes that have previously been shown to be retinoid-inducible (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) do not represent the initial cellular response(s) to the retinoids. For example, murine F9 teratocarcinoma stem cells, which differentiate in monolayer culture into parietal endoderm in response to retinoic acid (RA) (19) , do not begin to express higher levels of laminin B1, collagen IV (al), or other parietal endoderm-specific mRNAs until 18-24 hr after RA addition (10, 11, 13) . Moreover, the induction of collagen IV (al) and laminin B1 mRNAs by retinoic acid in F9 teratocarcinoma cells is prevented by inhibitors of protein synthesis such as cycloheximide (20) , suggesting that prior production of protein intermediate(s) is required for the induction of these genes.
To delineate the initial responses of F9 teratocarcinoma cells to RA, we have attempted to isolate genes that exhibit properties characteristic of a primary response to RA; such properties would include the rapid induction of the specific mRNA following RA addition, the dependence of the induction on the continuous presence of RA, and the complete induction of the specific mRNA by RA in the absence of protein synthesis. We have used a procedure in which cDNA was enriched for RA-induced sequences by subtractive hybridization (21) and used as a probe to isolate cDNA clones from a cDNA library of RA-treated (8 hr) F9 cells. With this procedure we have isolated the cDNA for a gene, early retinoic acid 1 (Era-i), which exhibits properties of a primary response to RA. The increase in Era-1 mRNA in response to RA represents a very early effect of RA at the RNA level in this system in which retinoids influence differentiation.
MATERIALS AND METHODS
Cell Culture and Nucleic Acid Isolation. F9 teratocarcinoma cells were cultured as described (13) . Total cellular RNA was isolated by the guanidine hydrochloride method essentially as described (13, 22, 23) . Poly(A)+ RNA was purified from total RNA by poly(U)-Sephadex column chromatography (24) . Genomic DNA was isolated as previously described (25) .
cDNA Library Construction and Screening. Poly(A) + RNA was isolated from F9 teratocarcinoma cells treated for 8 hr with RA/cAMP/T [1 ,tM RA/500 ,uM dibutyryl cAMP/500
,uM theophylline (all from Sigma)]. Using 12 ,ug of this poly(A)+ RNA, a cDNA library was constructed in the vector AgtlO with modifications of the Gubler and Hoffman procedure (26) , similar to those that have since been published (27, 28 (Fig. 1A) . In contrast, laminin B1 mRNA level does not increase significantly until 24-48 hr after RA addition (Fig. 1A) . When a high RA concentration (1 ,uM) is added exogenously, the Era-1 mRNA level increases 25-to 30-fold over a 48-hr period (Fig. 1A) , followed by a decline at 96 hr after RA addition (data not shown). The duration of this increase in mRNA level is dependent on the RA concentration. If a lower concentration of RA (10 nM) is added exogenously, the Era-1 mRNA level increases 15-fold by [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] hr, followed by a 50% decrease in level between 24-48 hr (Fig. 1B) . The more rapid decline in Era-1 mRNA after addition of 10 nM RA as compared with 1 ILM RA may be due to the conversion of RA to less active metabolites (34) .
When F9 cells are grown for 8 hr in medium containing 1 ,uM RA and then placed in medium without RA, a decrease in the Era-1 mRNA level results (Fig. 1C) . This suggests that RA must be present continuously for the increase in the level of the Era-1 mRNA to be maintained. This result is in striking contrast to the level of laminin B1 mRNA, which does not decrease upon the removal of exogenous RA at 8 hr. In fact, the laminin B1 mRNA level continues to increase for at least 40 hr after the removal of RA (Fig. 1C) .
We have previously shown that dibutyryl cAMP greatly enhances RA-induced expression of laminin B1 and collagen IV (al) mRNAs (13) . However, the RA-associated increase in Era-i mRNA is only slightly enhanced by concurrent exposure to dibutyryl cAMP (data not shown).
The magnitude of the increase in Era-i mRNA is dependent on the concentration of RA added exogenously to the F9 stem cells (Fig. 2 ). The concentration of RA which, 6 hr after addition, induces a half-maximal increase in the Era-i mRNA level is 2-4 nM. For comparison, the apparent dissociation constant of the F9 cellular RA-binding protein for RA is 9.2 + 1.1 nM (35) . The concentration of RA that induces a half-maximal increase in the laminin B1 mRNA level at 48 hr is also =4 nM (Fig. 2) . Thus, Era-1 mRNA is increased by concentrations of RA that are in the physiologic range, and the fact that the Era-1 dose-response curve correlates with the laminin B1 dose-response curve is consistent with the idea that the early increase in Era-1 mRNA is involved in the subsequent expression of genes such as laminin B1.
The (Fig. 3) . This demonstrates that protein synthesis is not required for the RAassociated increase in the level of Era-1 mRNA, implying that this increase may be a primary response to RA. In contrast, protein synthesis inhibitors prevent the induction of collagen IV (al) and laminin B1 mRNAs by RA (20) . The level of Era-1 mRNA is slightly higher after RA plus cycloheximide treatment than after RA treatment alone, and the Era-1 mRNA level in F9 stem cells is also slightly increased by cycloheximide (Fig. 3) . This increase may result from the nonspecific protection of mRNAs by ribosomes in the presence of the cycloheximide (36) .
Inhibitors of RNA synthesis such as actinomycin D do prevent the RA-associated increase in Era-1 mRNA (Fig. 3,  lanes 7 and 8) . By examining the steady-state level of Era-1 mRNA after actinomycin D addition, with or without simultaneous addition of RA, an estimate of the relative stability of the Era-1 mRNA in the presence or absence of RA can be obtained. Stability of the Era-1 mRNA is not appreciably altered in the presence of RA (Fig. 3, lanes 9 and 10) addition, total cellular RNA was isolated, and 2 j.g was analyzed by RNA blot hybridization as described. 32P-labeled cDNA insert probes were included at: Era-1, 1-3 x 106 cpm/ml; laminin B1, 1 x 106 cpm/ml; and actin, 0.5 x 106 cpm/ml. The mouse laminin B1 probe was a 980-bp fragment from pcI56 (10). The mouse actin probe was an insert from pAct-1 (33 (Fig. 3, lanes 7 and 8) . In these preliminary experiments, the half-lives of the laminin B1 and Era-1 mRNAs appear shorter than the half-life of actin mRNA, as no significant change in actin steady-state mRNA levels occurs after 6 hr of actinomycin D treatment. Characterization of the Era-] Gene. The Era-i gene encodes a polyadenylylated message (Fig. 4A ) that is not very abundant even after induction by RA. We estimate that before RA induction, the Era-1 .mRNA constitutes -0.O005% of total F9 stem cell poly(A)+ RNA, whereas after RA treatment, Era-1 mRNA reaches ='0.01-0.02% of F9 poly(A)+ RNA. This estimate was made by (i) comparison of intensities of bands on RNA gels, exposure times, and the concentrations and lengths of the Era-1 and laminin B1 probes used in the hybridizations, and (it) the frequency with which Era-1 cDNA clones were found in the RA/cAMP/T 8-hr library. Using more accurate methods, we had previously found the abundance of the laminin B1 mRNA to be 0.76% of the total poly(A)+ RNA population in differentiated F9 parietal endoderm cells (13) .
The Era-i gene is a single or low-copy number gene, as Southern analysis of an EcoRI digest of F9 genomic DNA revealed only one band of 8 kb hybridizing to the 5' half of the Era-1 cDNA (Fig. 4B) with an intensity equal to that for c-myc, a single-copy gene (data not shown). When a nearly full-length Era-i cDNA was used as a probe of an EcoRI F9 genomic digest, two bands of 8 kb and 4 kb were observed (data not shown).
DISCUSSION
The F9 teratocarcinoma stem -cell line has been widely used as an in vitro model system for the study of cellular differentiation, as well as the mechanism(s) by which RA influences this complex process. We and others (9-15, 17, 18 ) have previously characterized cDNA clones for cellular genes that show altered expression during the RA-induced Hybridizations of the Era-i and actin cDNAs to the RNA at 6 hr. (B) Hybridizations of the laminin B1 and actin cDNAs to the RNA at 48 hr. (C) The hybridizations of the Era-i cDNA to the 6-hr RA dose-response curve and the laminin B1 cDNA to the 48-hr RA dose-response curve were quantitated by scanning densitometry, normalized to actin mRNA, and plotted. differentiation of the F9 stem cells, such as those encoding certain homeobox-containing proteins (14) , cytoskeletal proteins (15, 17) , extracellular matrix proteins (10, 11, 13) and the major histocompatibility antigens (9) . The relatively slow 1 23456 78 S II changes in expression of these previously characterized genes following the addition of RA suggests that these changes are indirect effects of RA treatment and that more rapid, direct responses to RA exist.
In this paper, we report the isolation of Era-i, a gene that exhibits the properties of a primary target of RA action. The steady-state level of the Era-i mRNA is rapidly increased after addition of RA to the F9 teratocarcinoma stem cells (Fig. 1A) , which is in sharp contrast to previously reported developmentally regulated genes such as laminin B1, laminin B2, and collagen IV(al) (10, 11, 13) . In addition, the increase in Era-1 mRNA in the presence of RA does not require concurrent protein synthesis (Fig. 3) , indicating that no prior induction of gene expression, at either the transcriptional or translational level, is required for Era-1 mRNA expression. Era-1 mRNA expression is induced by physiologic concentrations of RA in a dose-dependent manner (Fig. 2) and requires the continued presence of RA (Fig. 1C) Finally, the further characterization of the putative Era-1 protein product is also of enormous interest. The observations that the Era-1 mRNA does not appear to be very abundant even after induction and that the dose-response of Era-1 mRNA induction at an early time correlates with the dose-response of laminin B1 mRNA induction at a later time after RA addition are consistent with the idea that the Era-] gene encodes a protein involved in the control of subsequent gene expression during differentiation. Further analysis of the Era-1 protein product and the introduction of the Era-i gene under a heterologous promoter into F9 stem cells will establish whether expression of the Era-1 protein is sufficient for the induction of late genes, such as laminin B1, laminin B2, and collagen IV(al) in the absence of RA.
